McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
683.51
+2.99 (0.44%)
At close: Aug 27, 2025, 4:00 PM
683.60
+0.09 (0.01%)
After-hours: Aug 27, 2025, 7:02 PM EDT
McKesson Market Cap
McKesson has a market cap or net worth of $85.02 billion as of August 27, 2025. Its market cap has increased by 18.99% in one year.
Market Cap
85.02B
Enterprise Value
92.54B
1-Year Change
18.99%
Ranking
Category
Stock Price
$683.51
Market Cap Chart
Since December 1, 1998, McKesson's market cap has increased from $7.05B to $85.02B, an increase of 1,106.22%. That is a compound annual growth rate of 9.75%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 27, 2025 | 85.02B | 17.52% |
Dec 31, 2024 | 72.34B | 17.43% |
Dec 29, 2023 | 61.61B | 15.82% |
Dec 30, 2022 | 53.19B | 40.15% |
Dec 31, 2021 | 37.95B | 35.91% |
Dec 31, 2020 | 27.93B | 12.04% |
Dec 31, 2019 | 24.92B | 15.48% |
Dec 31, 2018 | 21.58B | -33.61% |
Dec 29, 2017 | 32.51B | 2.39% |
Dec 30, 2016 | 31.75B | -30.03% |
Dec 31, 2015 | 45.38B | -5.71% |
Dec 31, 2014 | 48.13B | 29.83% |
Dec 31, 2013 | 37.08B | 62.00% |
Dec 31, 2012 | 22.89B | 19.63% |
Dec 30, 2011 | 19.13B | 7.42% |
Dec 31, 2010 | 17.81B | 6.34% |
Dec 31, 2009 | 16.75B | 58.13% |
Dec 31, 2008 | 10.59B | -44.13% |
Dec 31, 2007 | 18.96B | 26.34% |
Dec 29, 2006 | 15.01B | -5.46% |
Dec 30, 2005 | 15.87B | 71.66% |
Dec 31, 2004 | 9.25B | -1.34% |
Dec 31, 2003 | 9.37B | 19.10% |
Dec 31, 2002 | 7.87B | -26.43% |
Dec 31, 2001 | 10.70B | 4.95% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 630.35B |
Johnson & Johnson | 430.39B |
AbbVie | 367.89B |
UnitedHealth Group | 276.21B |
Novo Nordisk | 253.97B |
AstraZeneca | 251.25B |
Novartis AG | 246.51B |
Abbott Laboratories | 229.97B |